Dermata Therapeutics, Inc.DRMANASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank45
3Y CAGR-59.8%
5Y CAGR-53.7%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-59.8%/yr
Quarterly compound
5Y CAGR
-53.7%/yr
Recent deceleration
Percentile
P45
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 0.68% |
| Q2 2025 | 24.24% |
| Q1 2025 | 26.89% |
| Q4 2024 | 0.79% |
| Q3 2024 | -11.86% |
| Q2 2024 | 9.98% |
| Q1 2024 | -44.30% |
| Q4 2023 | -22.52% |
| Q3 2023 | -4.59% |
| Q2 2023 | 23.94% |
| Q1 2023 | -33.07% |
| Q4 2022 | 30.02% |
| Q3 2022 | 10.43% |
| Q2 2022 | 1.97% |
| Q1 2022 | -9.13% |
| Q4 2021 | -49.09% |
| Q3 2021 | -28.75% |
| Q2 2021 | 41.20% |
| Q1 2021 | -360.29% |
| Q4 2020 | 9.01% |
| Q3 2020 | 31.88% |
| Q2 2020 | 41.21% |
| Q1 2020 | 0.00% |